Literature DB >> 4170954

Studies on the in vitro behavior of agammaglobulinemic lymphocytes.

S R Cooperband, F S Rosen, S Kibrick.   

Abstract

Circulating lymphocytes from patients with congenital X-linked agammaglobulinemia, sporadic congenital agammaglobulinemia, and acquired agammaglobulinemia have been cultured in vitro. They have been shown to proliferate in a normal manner under stimulus of phytohemagglutinin and antigens to which the patient was sensitized. Agammaglobulinemic cells have been shown to synthesize protein at a rate similar to that of normal cells, and the character of the extracellular protein produced is also similar. Agammaglobulinemic lymphocytes have been found to produce a small quantity of immunoglobulin G, similar to that found in normal cell cultures. The quantity of immunoglobulin produced may be increased by exposure of the cells to phytohemagglutinin. From these data, it appears that the basic lesion responsible for agammaglobulinemia is not a deficiency in lymphocyte-mediated antigen recognition or cellular proliferation. It would also appear that the basic deficiency in these disorders does not involve the structural or regulatory genes necessary for the synthesis of immunoglobulins. By exclusion, the pathogenesis of the deficiency would appear to involve cells other than circulating lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4170954      PMCID: PMC297233          DOI: 10.1172/JCI105777

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  FAILURE OF LYMPHOCYTES FROM HYPOGAMMAGLOBULINAEMIC SUBJECTS TO TRANSFORM IN CULTURE.

Authors:  M W ELVES; S ROATH; M C ISRAELS
Journal:  Br Med J       Date:  1964-10-24

2.  GAMMA-GLOBULIN PRODUCTION BY HUMAN LYMPHOCYTES IN VITRO.

Authors:  F BACH; K HIRSCHHORN
Journal:  Exp Cell Res       Date:  1963-12       Impact factor: 3.905

3.  [Three cases of agammaglobulinemia; a clinical, genetic and physical chemical contribution to the knowledge of protein metabolism].

Authors:  N KULNEFF; K O PEDERSEN; J WALDENSTROM
Journal:  Schweiz Med Wochenschr       Date:  1955-04-16

4.  Tuberculin-induced mitosis in peripheral blood leucocytes.

Authors:  G PEARMAIN; R R LYCETTE; P H FITZGERALD
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

5.  Purification and measurement of microgram amounts of radioactive nucleic acids and proteins from animal cells in tissue culture.

Authors:  F M KAHAN
Journal:  Anal Biochem       Date:  1960-09       Impact factor: 3.365

6.  Homograft rejection in children with congenital immunological defects: agammaglobulinemia and Aldrich syndrome.

Authors:  W K SCHUBERT; R FOWLER; L W MARTIN; C D WEST
Journal:  Plast Reconstr Surg       Date:  1960-07       Impact factor: 4.730

7.  Chromatography of serum proteins in normal and pathologic sera: the distribution of protein-bound carbohydrate and cholesterol, siderophilin, thyroxin-binding protein, B12-binding protein, alkaline and acid phosphatases, radio-iodinated albumin and myeloma proteins.

Authors:  J L FAHEY; P F McCOY; M GOULIAN
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

8.  Purification and characterization of tetanus toxoid and toxin. I. Fractionation of tetanus toxoid by gel filtration.

Authors:  W C Latham; C P Jenness; R J Timperi; C B Michelsen; E M Zipilivan; G Edsall; H L Ley
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

9.  Synthesis of proteins by human leukocytes in vitro. II. Chemical characterization.

Authors:  K J Turner; I J Forbes
Journal:  J Immunol       Date:  1966-06       Impact factor: 5.422

10.  Dissociation and inhibition of the stimulatory effect of phytohaemagglutinin on protein and DNA synthesis in human lymphocyte cultures.

Authors:  S R Cooperband; J A Green; M A Kennedy; M M Grant
Journal:  Nature       Date:  1967-06-17       Impact factor: 49.962

View more
  7 in total

1.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

2.  Immunoglobulin synthesis by human peripheral lymphocytes and thymocytes in vitro. Specificity of immunochemical methods and stimulation by phytohaemagglutinin.

Authors:  I J Forbes; J L Smith
Journal:  Clin Exp Immunol       Date:  1969-12       Impact factor: 4.330

3.  Response of agammaglobulinaemic lymphocytes in mixed lymphocyte culture.

Authors:  E Lieber; K Hirschhorn; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  Sensitivity to encephalitogenic protein in optic neuritis.

Authors:  S Lessell; P Behan; J Lamarche; M Kies
Journal:  Br J Ophthalmol       Date:  1970-11       Impact factor: 4.638

5.  Sensitivity of non-human cells to human lymphocyte 'proliferation inhibitory factor' (PIF) in vitro.

Authors:  A M Badger; S R Cooperband; V J Merluzzi; J A Green
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

6.  Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies.

Authors:  F Aiuti; V Lacava; J A Garofalo; R D'Amelio; C D'Asero
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

7.  Studies on rabbit lymphocytes in vitro. 8. The relationship between heterozygosity and homozygosity of lymphocyte donor and per cent blast transformation induced by antiallotype sera.

Authors:  S Sell
Journal:  J Exp Med       Date:  1968-06-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.